Joyzyme Group Limited (HKG:8622)
0.3600
-0.0100 (-2.78%)
Feb 13, 2026, 3:55 PM HKT
Joyzyme Group Market Cap
Joyzyme Group has a market cap or net worth of 185.57 million as of February 13, 2026. Its market cap has increased by 45.41% in one year.
Market Cap
185.57M
Enterprise Value
149.91M
Revenue
28.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
Market Cap Chart
Since December 13, 2018, Joyzyme Group's market cap has decreased from 188.00M to 185.57M, a decrease of -1.29%. That is a compound annual growth rate of -0.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 185.57M | -17.24% |
| Dec 31, 2025 | 224.23M | 198.69% |
| Dec 31, 2024 | 75.07M | 67.66% |
| Dec 29, 2023 | 44.78M | -41.60% |
| Dec 30, 2022 | 76.68M | -22.70% |
| Dec 31, 2021 | 99.20M | 131.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 647.70M |
| Fusen Pharmaceutical Company | 554.48M |
| China NT Pharma Group Company | 519.17M |
| Wai Yuen Tong Medicine Holdings | 416.29M |
| Regent Pacific Group | 294.73M |
| Shenzhen Neptunus Interlong Bio-technique Company | 266.80M |
| Tianda Pharmaceuticals | 221.45M |
| Extrawell Pharmaceutical Holdings | 201.45M |